Interestingly, Trp53 and Rb1 signaling has been shown to inhibit YAP activity in tumors such as pancreatic cancer and retinoblastoma,24, 25 highlighting the crucial role of Trp53 and Rb1 expression as a barrier to tumor progression. This evidence concerns the gene RB1 and retinoblastoma.